Stock News
Categories
- All
- Editor's Picks
- Stock Analysis
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Instant Alerts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
Utilities - Regulated
Exelon Corp (EXC) Q3 2024 Earnings Call Highlights: Strong Earnings Amid Regulatory and Market Challenges
Exelon Corp (EXC) reports robust earnings growth and strategic investments while navigating regulatory complexities and market reforms. Oct 31, 2024
Drug Manufacturers
Eli Lilly and Co (LLY) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Investments Propel Performance
Driven by new product successes and strategic investments, Eli Lilly and Co (LLY) reports a 42% revenue increase, setting a strong foundation for future growth. Oct 31, 2024
Building Materials
Martin Marietta Materials Inc (MLM) Q3 2024 Earnings Call Highlights: Strategic Acquisitions and Record Cash Flows Amid Weather Challenges
Despite a decrease in revenue, Martin Marietta Materials Inc (MLM) reports record cash flows and strategic growth initiatives, positioning for a strong 2025. Oct 31, 2024
Construction
Trane Technologies PLC (TT) Q3 2024 Earnings Call Highlights: Strong Growth and Raised Guidance
Trane Technologies PLC (TT) reports robust Q3 2024 performance with 11% organic revenue growth and raises full-year guidance amid challenges in Asia Pacific. Oct 31, 2024
Industrial Products
Illinois Tool Works Inc (ITW) Q3 2024 Earnings Call Highlights: Navigating Revenue Declines with Strategic Margin Expansion
Despite a dip in organic revenue, Illinois Tool Works Inc (ITW) showcases robust EPS growth and strategic financial maneuvers in Q3 2024. Oct 31, 2024
Oil & Gas
EQT Corp (EQT) Q3 2024 Earnings Call Highlights: Record Efficiency and Strategic Moves Amid Market Volatility
EQT Corp (EQT) reports strong financial performance, strategic acquisitions, and efficiency gains, while navigating integration challenges and market uncertainties. Oct 31, 2024
Consumer Packaged Goods
The Kraft Heinz Co (KHC) Q3 2024 Earnings Call Highlights: Strong Global Growth Amid US Retail Challenges
The Kraft Heinz Co (KHC) showcases robust cash flow and brand growth, while navigating headwinds in the US retail segment. Oct 31, 2024
Drug Manufacturers
AbbVie Inc (ABBV) Q3 2024 Earnings Call Highlights: Strong Growth in Ex-Humira Platform and Dividend Increase
AbbVie Inc (ABBV) reports robust sales growth driven by Skyrizi and Rinvoq, raises full-year guidance, and announces a 5.8% dividend increase. Oct 31, 2024
Agriculture
FMC Corp (FMC) Q3 2024 Earnings Call Highlights: Strong Sales Growth Amid Market Challenges
FMC Corp (FMC) reports robust third-quarter performance with significant sales growth in North America, while navigating challenges in Latin America and Asia. Oct 31, 2024
Healthcare Plans
Humana Inc (HUM) Q3 2024 Earnings Call Highlights: Strong EPS Guidance and Strategic Expansion Amid Challenges
Humana Inc (HUM) reports robust growth and strategic investments, while addressing challenges in drug costs and membership retention. Oct 31, 2024
Utilities - Regulated
FirstEnergy Corp (FE) Q3 2024 Earnings Call Highlights: Strategic Investments and Storm Challenges
FirstEnergy Corp (FE) reports stable earnings amidst increased capital investments and significant storm restoration costs. Oct 31, 2024
Hardware
TE Connectivity PLC (TEL) Q4 2024 Earnings Call Highlights: Record Margins and Strategic Growth Amid Market Challenges
TE Connectivity PLC (TEL) reports robust earnings and strategic advancements, despite facing headwinds in global markets. Oct 31, 2024
Healthcare Providers & Services
GE HealthCare Technologies Inc (GEHC) Q3 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic Growth Initiatives
Despite headwinds in China, GE HealthCare Technologies Inc (GEHC) reports strong backlog growth and strategic investments in AI and precision medicine. Oct 31, 2024
Biotechnology
Bio-Techne Corp (TECH) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges in a Dynamic Market
Bio-Techne Corp (TECH) reports steady revenue growth and strategic advancements despite facing margin pressures and challenges in the Chinese market. Oct 31, 2024
Industrial Products
Otis Worldwide Corp (OTIS) Q3 2024 Earnings Call Highlights: Navigating Challenges and Capitalizing on Service Growth
Despite headwinds in China, Otis Worldwide Corp (OTIS) reports robust service growth and strategic advancements in modernization. Oct 31, 2024
Software
CDW Corp (CDW) Q3 2024 Earnings Call Highlights: Navigating Market Challenges with Strategic Growth in Cloud and Services
Despite a decline in net sales, CDW Corp (CDW) focuses on expanding cloud and software services to drive future growth. Oct 31, 2024
Drug Manufacturers
Biogen Inc (BIIB) Q3 2024 Earnings Call Highlights: Navigating Revenue Declines and Strategic Growth Opportunities
Despite challenges in key segments, Biogen Inc (BIIB) raises EPS guidance and showcases promising growth in its rare disease franchise and pipeline potential. Oct 31, 2024
Business Services
Verisk Analytics Inc (VRSK) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Shareholder Returns
Verisk Analytics Inc (VRSK) reports a 7% revenue increase and robust subscription growth, while navigating transactional revenue challenges and market uncertainties. Oct 31, 2024
Insurance
Chubb Ltd (CB) Q3 2024 Earnings Call Highlights: Strong Growth in Core Operating Income and Investment Returns
Chubb Ltd (CB) reports robust double-digit growth in core operating EPS and investment income, despite challenges in the competitive London market. Oct 31, 2024
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers